Pomalidomide

Pomalidomide (Imnovid®) is an immunomodulatory medication used to treat multiple myeloma. It belongs to a class of drugs known as thalidomide analogs and works by modulating the immune system, altering the production of certain inflammatory proteins, and inhibiting the growth of cancer cells. It is usually taken orally once daily in combination with low-dose dexamethasone. Common side effects include anemia, constipation, diarrhea, dizziness, fatigue, fever, headache, and insomnia.

Pomalidomide is a medication used for the treatment of certain types of blood cancers, specifically:

  • Multiple myeloma: This is a cancer of plasma cells, a type of white blood cell found in bone marrow. Pomalidomide is typically used in combination with other medications for multiple myeloma.
  • Mantle cell lymphoma (MCL): This is a rare form of cancer that affects lymphocytes (white blood cells) in the lymph nodes.

Here's a breakdown of how Pomalidomide works and some key points to consider:

Mechanism of Action:

The exact way Pomalidomide works in treating cancer is still being researched, but it's believed to have several effects on cancer cells:

  • Immunomodulatory activity: It might help boost the immune system's ability to recognize and attack cancer cells.
  • Anti-angiogenesis: It may interfere with the formation of new blood vessels that tumors need to grow and survive.
  • Cell cycle arrest: Pomalidomide might stop cancer cells from dividing and multiplying.

Dosage and Administration:

  • Pomalidomide is typically taken orally (by mouth) as a capsule, once a day.
  • The dosage is determined by your doctor based on your individual needs, type of cancer, and other factors.

Considerations:

  • Serious Side Effects: Pomalidomide can cause serious side effects, including blood clots, low blood counts, birth defects, and nerve damage. It's crucial to be aware of these risks and to be monitored closely by your doctor while taking this medication.
  • Pregnancy: Pomalidomide is strictly contraindicated for pregnant women due to the high risk of severe birth defects. Women taking Pomalidomide should use effective birth control methods.
  • Blood Tests: Regular blood tests are necessary while taking Pomalidomide to monitor blood cell counts and check for potential side effects.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AX Other immunosuppressants
External Links